Literature DB >> 10626903

Pertussis toxin treatment in vivo reduces surface expression of the adhesion integrin leukocyte function antigen-1 (LFA-1).

A R Schenkel1, C D Pauza.   

Abstract

Pertussis toxin treatment in macaques inhibits lymphocyte extravasation from the blood and leads to transient lymphocytosis and leukocytosis. We examined lymphocyte adhesion molecules known to be involved in the extravasation process to find possible mechanisms for the effects of pertussis toxin treatment. The two subunits of LFA-1, CD11a and CD18, showed decreased surface expression on lymphocytes from pertussis toxin treated animals compared to untreated animals. The adhesion molecule CD44, and the alpha subunit of the integrin VLA-4 (CD49d) were not decreased by pertussis toxin treatment. Lower surface expression of CD11a and CD18 was observed on all lymphocyte subsets and was correlated inversely with the extent of lymphocytosis. The magnitude of lymphocytosis after pertussis toxin treatment was higher in SIV-infected macaques than in uninfected animals. However, changes in LFA-1 levels were similar in both groups. These data show that LFA-1 surface levels are affected by pertussis toxin in vivo and this change may account in part, for the ability of pertussis toxin to induce lymphocytosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10626903     DOI: 10.3109/15419069909010801

Source DB:  PubMed          Journal:  Cell Adhes Commun        ISSN: 1023-7046


  7 in total

Review 1.  Pertussis leukocytosis: mechanisms, clinical relevance and treatment.

Authors:  Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2016-09-07       Impact factor: 3.166

Review 2.  Contribution of pertussis toxin to the pathogenesis of pertussis disease.

Authors:  Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2015-09-21       Impact factor: 3.166

3.  Fatal Pertussis in the Neonatal Mouse Model Is Associated with Pertussis Toxin-Mediated Pathology beyond the Airways.

Authors:  Karen M Scanlon; Yael G Snyder; Ciaran Skerry; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

Review 4.  Toward a mechanism-based in vitro safety test for pertussis toxin.

Authors:  Stefan F C Vaessen; Martijn W P Bruysters; Rob J Vandebriel; Saertje Verkoeijen; Rogier Bos; Cyrille A M Krul; Arnoud M Akkermans
Journal:  Hum Vaccin Immunother       Date:  2014-02-19       Impact factor: 3.452

5.  Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.

Authors:  Karen Scanlon; Ciaran Skerry; Nicholas Carbonetti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 6.  Association of Pertussis Toxin with Severe Pertussis Disease.

Authors:  Karen Scanlon; Ciaran Skerry; Nicholas Carbonetti
Journal:  Toxins (Basel)       Date:  2019-06-27       Impact factor: 4.546

Review 7.  Impact of Bacterial Toxins in the Lungs.

Authors:  Rudolf Lucas; Yalda Hadizamani; Joyce Gonzales; Boris Gorshkov; Thomas Bodmer; Yves Berthiaume; Ueli Moehrlen; Hartmut Lode; Hanno Huwer; Martina Hudel; Mobarak Abu Mraheil; Haroldo Alfredo Flores Toque; Trinad Chakraborty; Jürg Hamacher
Journal:  Toxins (Basel)       Date:  2020-04-02       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.